Concepedia
Publication | Open Access
Avelumab Plus Talazoparib in Patients With <i>BRCA1/2</i>- or <i>ATM</i>-Altered Advanced Solid Tumors
54
Citations
31
References
2022
Year
ClinicalTrials.gov Identifier: NCT03565991.
Page 1